<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03712735</url>
  </required_header>
  <id_info>
    <org_study_id>H18-02318</org_study_id>
    <nct_id>NCT03712735</nct_id>
  </id_info>
  <brief_title>Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women</brief_title>
  <official_title>Effect of Programmed Intermittent Epidural Bolus Delivery Rate on the Quality of Labour Analgesia: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of three programmed intermittent epidural bolus (PIEB) pump settings for
      maintenance of labour analgesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The optimal PIEB and patient controlled epidural administered (PCEA) bolus settings are still
      unknown. Therefore, in this study, the investigators aim to compare analgesia outcomes both
      high and low PIEB flow rate settings.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 23, 2018</start_date>
  <completion_date type="Anticipated">July 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breakthrough pain</measure>
    <time_frame>Duration of labor with epidural</time_frame>
    <description>Proportion of patients in each group who required a provider administered supplemental bolus for breakthrough pain</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine 0.08% - fentanyl 2mcg on the following pump settings:
PIEB flow rate = high; interval = 60 min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bupivacaine 0.08% - fentanyl 2mcg on the following pump settin PIEB flow rate = high; interval = 45 min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bupivacaine 0.08% - fentanyl 2mcg on the following pump settin PIEB flow rate = low; interval = 45 min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.08% - fentanyl 2mcg</intervention_name>
    <description>In each arm, bupivacaine and fentanyl are being delivered at different intervals and rates for the maintenance of labor analgesia.</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton, vertex presentations at term (37-42 weeks gestational age)

          -  &lt;/= 5cm cervical dilation at the time of epidural anesthesia request

          -  ASA 2-3 patients aged 19 or over who are able to provide informed consent

        Exclusion Criteria:

          -  Contraindications to neuraxial analgesia or risk factors likely to affect placement or
             function of the epidural

          -  History of hypersensitivity or idiosyncratic reaction to local anesthetics or opioids

          -  Current or historical evidence of any significant medical conditions

          -  Clinical settings in which continuous epidural infusion may be preferable

          -  Risk factors significantly increasing the need for Cesarean delivery

          -  Anticipated fetal abnormalities
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anton Chau, MD MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>James D Taylor, BSc</last_name>
    <phone>604-875-2424</phone>
    <phone_ext>6076</phone_ext>
    <email>james.taylor1@phsa.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelly Au, BSc MD</last_name>
    <phone>604-875-2424</phone>
    <phone_ext>6076</phone_ext>
    <email>kelly.au@cw.bc.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>BC Women's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James D Taylor, BSc</last_name>
      <phone>604-875-2424</phone>
      <phone_ext>6076</phone_ext>
      <email>james.taylor1@phsa.ca</email>
    </contact>
    <contact_backup>
      <last_name>Kelly Au, BSc MD</last_name>
      <phone>604-875-2424</phone>
      <phone_ext>6076</phone_ext>
      <email>kelly.au@cw.bc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Anton Chau, MD MMSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kelly Au, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zahid Sunderani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Taylor, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arianne Albert, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Massey, MB BCh FRCPC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roanne Preston, MD FRCPC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>October 17, 2018</study_first_submitted>
  <study_first_submitted_qc>October 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2018</study_first_posted>
  <last_update_submitted>February 12, 2019</last_update_submitted>
  <last_update_submitted_qc>February 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Anton Chau</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Labor analgesia</keyword>
  <keyword>Programmed intermittent epidural bolus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

